Harnessing Tumour Models to Explore CD40 Therapies on Tumour Myeloid Cell Populations

Time: 4:00 pm
day: Conference Day One


  • Discussing the relevance and translational potential of 2D culture models for understanding the mechanisms and optimizing CD40-based therapies
  • Examining the effects of CD40 agonists or combination therapies on myeloid cell polarization, antigen presentation, and T cell activation
  • Presenting and interpreting data from dissociated tumour models in 2D culture to elucidate the mechanistic insights and identify potential therapeutic strategies